drugset / Trial / NCT04958512
Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill
RandomizedParallel-groupDouble-blindTreatment
Summary
In this study, the effectiveness of vascular cognitive impairment was compared among the three groups, namely, the xidezhen group, the Yangxue Qingnao pill group and the placebo group
Timeline
- Start
- 2017-08-30
- Primary completion
- 2018-01-31
- Completion
- 2018-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hydergotoxine mesylate | Unknown | 3 mg | — |
| Subject | Yangxue Qingnao pill | Unknown | 2.5 g | Oral |